Skip to content

Drug interactions

Duvelisib + Solifenacin

Severity: Moderate

Duvelisib and Solifenacin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Duvelisib inhibits CYP3A4 and can raise solifenacin exposure. This increases the risk of anticholinergic adverse effects and possibly QT prolongation.

What this interaction means in plain words

Duvelisib and Solifenacin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Duvelisib belongs to Oncology; Solifenacin belongs to Genitourinary.

Evidence level: Moderate

Why it happens

Duvelisib inhibits CYP3A4, reducing the first-pass and systemic metabolism of solifenacin.

What to do

Monitor for anticholinergic toxicity such as urinary retention, constipation and blurred vision. Consider a lower solifenacin dose, and do not exceed 5 mg daily where CYP3A4 inhibition is significant.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Duvelisib and Solifenacin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Duvelisib with Solifenacin?

MediHelp rates the interaction as moderate. Duvelisib and Solifenacin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Duvelisib inhibits CYP3A4 and can raise solifenacin exposure. This increases the risk of anticholinergic adverse effects and possibly QT prolongation.

How serious is the interaction between Duvelisib and Solifenacin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for anticholinergic toxicity such as urinary retention, constipation and blurred vision. Consider a lower solifenacin dose, and do not exceed 5 mg daily where CYP3A4 inhibition is significant.

What other medicines interact with Solifenacin?

MediHelp also lists interactions of Solifenacin with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Solifenacin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in